The Future of

Bio/Pharmaceutical Analysis

Online Summit 2024

Now On-Demand

Speakers

20 June

Speakers

Radhakrishna Tirumalai

Radhakrishna Tirumalai

Senior Principal Scientist

Merck Research Laboratories

Merck logo

Radhakrishna Tirumalai is recognized author, speaker, pharmacopeial expert, and microbiology expert with over 25 years experience in biopharmaceuticals and pharmaceuticals.

Dr. Tirumalai is currently a Senior Principal Scientist at Merck Research Laboratories (MRL), Center for Excellence in Microbiology, providing above site support to all MRL sites on all Microbiology related issues (Sterile and Nonsterile). He also interfaces with Merck Manufacturing Division internally and external trade associations and regulatory agencies.

He was at the USP, 2003-2022, in various roles and most recently as a Senior Principal Scientist-General Chapters, in the Science Division. He was the Liaison to the USP Expert Committee on Microbiology. He worked on the development and revision of General Chapters. Dr. Tirumalai represented USP on PDA expert task forces and committees related to Microbiology and Sterility Assurance 2005-2022, the organizing committee of PDA Global Microbiology Conference 2006-2018, on AAMI expert working groups related to Microbiology, Sterilization, Sterility Assurance and Biocompatibility 2004-2022, and on the editorial board of FDA’s Pharmaceutical Microbiology Manual from 2012-2022.

He has authored numerous publications, review articles and several book chapters. He has organized numerous workshops and conferences and is a frequent speaker at conferences and has taught Pharmacopeial Microbiology courses at numerous locations globally.

Lonza logo
Panel

2.15 – 3.15 pm CET

Endotoxin testing:

The future of recombinant methods

With an ever-increasing focus on sustainability across the pharmaceutical industry, many companies are looking to recombinant methods for bacterial endotoxin testing. During this panel discussion, experts will discuss the latest guidelines and regional variations on recombinant Factor C (rFC) and recombinant Cascade Reagents (rCR). Make sure you join to:

  • Stay up to date with landscape surrounding the use of rFC and rCR
  • Learn about different approaches and strategies for method validation
  • Evaluate different technologies that can support your BET needs
Allen Burgenson with Lonza logo

Allen Burgenson

SME Testing Services
Lonza

Phil Duncanson with AstraZeneca logo

Phil Duncanson

Chief Microbiologist, Global Quality
AstraZeneca

Ingo Spreitzer with Paul-Ehrlich-Institut logo

Ingo Spreitzer

Deputy Head Microbiology Safety Section
Paul-Ehrlich-Institut

Radhakrishna Tirumalai with Merck logo

Radha Tirumalai

Senior Principal Scientist
Merck Research Laboratories

Tim Sandle with Bio Products Laboratory logo

Moderator: Dr Tim Sandle

Head of QA GxP Compliance and Sterility Assurance
Bio Products Laboratory